Bilaketaren emaitzak - Pierfranco Conté

Findu emaitzak
  1. 1
    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens

    Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens nork Pierfranco Conté, Valentina Guarneri

    Argitaratua 2004
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy

    Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy nork Valentina Guarneri, Pierfranco Conté

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations nork Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature

    Effects of Sulfonylureas on Tumor Growth: A Review of the Literature nork Giulia Pasello, Loredana Urso, Pierfranco Conté, Adolfo Favaretto

    Argitaratua 2013
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa

    Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice Versa nork Massimo Dominici, Paolo Paolucci, Pierfranco Conté, Edwin M. Horwitz

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities nork Maria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

    Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges nork Alberto Pavan, Ilaria Attili, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Laura Bonanno

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Cognitive impairment following breast cancer treatments: an umbrella review

    Cognitive impairment following breast cancer treatments: an umbrella review nork Giulia Oliva, Andreina Giustiniani, Laura Danesin, Francesca Burgio, Giorgio Arcara, Pierfranco Conté

    Argitaratua 2024
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma

    Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma nork Michela Maur, Chiara Tomasello, Antonio Frassoldati, Maria Vittoria Dieci, Elena Barbieri, Pierfranco Conté

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials

    Survival after neoadjuvant therapy with trastuzumab–lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials nork Valentina Guarneri, Gaia Griguolo, Federica Miglietta, Pierfranco Conté, Maria Vittoria Dieci, Fabio Girardi

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

    Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide nork Serafino Ricci, Andrea Antonuzzo, Luca Galli, M Ferdeghini, Lisa Bodei, Cinzia Orlandini, Pierfranco Conté

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer nork Laura Bonanno, Elisabetta Zulato, Alberto Pavan, Ilaria Attili, Giulia Pasello, Pierfranco Conté, Stefano Indraccolo

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability

    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability nork Błażej Cieślik, Justyna Mazurek, Adam Wrzeciono, Lorenza Maistrello, Joanna Szczepańska-Gieracha, Pierfranco Conté, Paweł Kiper

    Argitaratua 2023
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

    Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials nork Maria Vittoria Dieci, M.‐C. Mathieu, Valentina Guarneri, Pierfranco Conté, Suzette Delaloge, Fabrice André, Aïcha Goubar

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer

    Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer nork Giulia Pasello, Alberto Pavan, Ilaria Attili, Alberto Bortolami, Laura Bonanno, Jessica Menis, Pierfranco Conté, Valentina Guarneri

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer

    Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer nork Alessandra Gennari, Dino Amadori, Mario De Lena, Oriana Nanni, Paolo Bruzzi, Vito Lorusso, Luigi Manzione, Pierfranco Conté

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

    Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis nork Maria Vittoria Dieci, Elena Barbieri, Federico Piacentini, Guido Ficarra, Stefania Bettelli, Massimo Dominici, Pierfranco Conté, Valentina Guarneri

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation

    Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation nork Massimo Dominici, Roberta Marino, Valeria Rasini, Carlotta Spano, Paolo Paolucci, Pierfranco Conté, Ted J. Hofmann, Edwin M. Horwitz

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

    Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based c... nork Alessandro Buda, Irene Floriani, R Rossi, Nicoletta Colombo, Valter Torri, Pierfranco Conté, R. Fossati, Alessandra Ravaioli, Costantino Mangioni

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?

    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? nork Laura Bonanno, Alessandro Dal Maso, Alberto Pavan, Elisabetta Zulato, Lorenzo Calvetti, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Stefano Indraccolo

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: